Diabetic Neuropathy and PAD Testing With the TM Flow System
Filed under TM Flow System

Diabetes Complications at Every Stage, From Prediabetes to Long-Standing Diabetes
November is American Diabetes Month, a time when many practices focus on diabetes awareness, prevention, and care.
Diabetes care does not look the same for every patient. A patient with prediabetes, a patient with a new diagnosis, and a patient who has managed diabetes for many years may all be seen in the same week. Their concerns are different, and so are the questions providers need to answer.
What these patients share is risk. Diabetes and other chronic metabolic conditions can affect circulation, small nerve fibers, and autonomic function, sometimes before symptoms make those changes obvious.
The TM Flow System provides objective vascular, sudomotor, and autonomic information that can support evaluation at each stage of the patient’s course.
Objective Vascular and Nerve Data in One Assessment
The TM Flow System brings several assessments together in one 7 to 10 minute session.
Its assessments include ankle-brachial index testing for vascular evaluation, sudomotor testing related to small fiber nerve function, and autonomic function testing through heart rate variability analysis.
Together, those findings can provide a broader view of patients whose risk may involve poor circulation, neuropathic dysfunction, cardiometabolic disease, or a combination of factors.
Prediabetes: Early Vascular and Autonomic Changes
Patients with prediabetes are often focused on lab values. They want to know whether their A1c has changed and whether a diabetes diagnosis can be avoided.
For providers, the broader picture may include cardiometabolic risk that is already developing. Early vascular or autonomic changes do not always produce symptoms.
The TM Flow System is designed to support early detection of chronic metabolic disease and its complications. Testing at this stage can provide objective findings to consider alongside lab results and other risk factors.
It can also establish a reference point. If the patient’s condition changes, providers have earlier findings available for comparison.
New Diabetes Diagnosis: Baseline ABI, Sudomotor and Autonomic Testing
A new diabetes diagnosis brings many priorities, including medications, glucose monitoring, nutrition, and patient education.
It is also an important time to understand where the patient stands. Some patients may already have vascular or nerve-related changes at diagnosis, even without significant complaints.
TM Flow testing at diagnosis can document a starting point. ABI findings support vascular evaluation in the lower extremities. Sudomotor findings provide information related to small fiber nerve function. Autonomic testing adds another view of how the body is responding to metabolic disease.
With that information documented, future results can be reviewed in context rather than in isolation.
Long-Standing Diabetes: Monitoring Diabetic Neuropathy and PAD
Patients who have lived with diabetes for many years often face a different set of concerns.
They may report burning, tingling, numbness, fatigue, or discomfort with walking. Others may report few symptoms even as complications develop. Because poor circulation and neuropathy can overlap, symptoms alone may not make the underlying contributor obvious.
The TM Flow System allows providers to review vascular and nerve-related findings together.
When repeat testing is appropriate, providers can review whether objective findings appear to be improving, remaining stable, or declining. Cardiometabolic summary scores and individual test results can be reviewed over time to help identify trends.
In-Office Diabetes Complications Testing in 7 to 10 Minutes
One practical benefit of the TM Flow System is that the same assessment can be used across each stage of diabetes care.
Testing is non-invasive, requires no dedicated room, and can be performed by trained clinical staff. That makes it practical to include in existing clinic workflows.
The TM Flow System does not replace clinical judgment. It gives providers additional objective information to bring into that judgment.
American Diabetes Month: Objective Testing at Every Stage
Diabetes is not a single moment in a patient’s life. It is a condition that develops and changes over time.
When a patient has prediabetes, objective testing can help identify early changes and establish a baseline. When a patient is newly diagnosed, testing can document a starting point. When a patient has lived with diabetes for years, repeat testing can help providers follow vascular and nerve-related findings over time.
The TM Flow System gives providers vascular, sudomotor, and autonomic data that supports a more complete view of the patient’s course at every stage of diabetes care.
For more information on the TM Flow System, call Primary Care Diagnostics at (731) 234-5095 or (423) 914-2986.
Request More Information
Message received
Thank you. We will be in touch soon.
Need immediate assistance? Call us: (731) 234-5095 or (423) 914-2986
